69 related articles for article (PubMed ID: 26998667)
1. Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype.
Yang X; Li R; Fu F; Zhang Y; Li D; Liao C
J Matern Fetal Neonatal Med; 2017 Jan; 30(2):194-198. PubMed ID: 26998667
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphism array (SNP-array) analysis for fetuses with abnormal nasal bone.
Xie X; Su L; Li Y; Shen Q; Wang M; Wu X
Arch Gynecol Obstet; 2024 Jun; 309(6):2475-2482. PubMed ID: 37430178
[TBL] [Abstract][Full Text] [Related]
3. Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35.
Huang J; Wu D; He JH; Wang JY; Li X; Wang ZY; Wang Y; Liu HY
Front Med (Lausanne); 2024; 11():1376319. PubMed ID: 38633307
[TBL] [Abstract][Full Text] [Related]
4. The likelihood of detecting abnormal karyotypes in fetuses with a single major anomaly or "soft" marker on ultrasonographic scanning.
Petrovic B; Milicevic S; Sljivancanin D; Zdelar Stojanovic L; Stamenkovic J; Grk M; Dusanovic Pjevic M
Clin Dysmorphol; 2024 Jul; 33(3):137-144. PubMed ID: 38410977
[TBL] [Abstract][Full Text] [Related]
5. Is nuchal translucency of 3.0-3.4 mm an indication for cfDNA testing or microarray? - a multicenter retrospective clinical cohort study.
Rybak-Krzyszkowska M; Madetko-Talowska A; Szewczyk K; Bik-Multanowski M; Sakowicz A; Stejskal D; Trková M; Smetanová D; Serafim S; Correia H; Nevado J; Angeles Mori M; Mansilla E; Rutkowska L; Kucińska A; Gach A; Huras H; Kołak M; Srebniak MI
Fetal Diagn Ther; 2024 May; ():. PubMed ID: 38815555
[TBL] [Abstract][Full Text] [Related]
6. Genomic characterization of some Iranian children with idiopathic mental retardation using array comparative genomic hybridization.
Behjati F; Firouzabadi SG; Kariminejad R; Vameghi R; Sajedi F; Shafaghati Y; Ghasemlou BE; Shojaei A; Jamali P; Bahman I; Najmabadi H
Indian J Hum Genet; 2013 Oct; 19(4):443-8. PubMed ID: 24497710
[TBL] [Abstract][Full Text] [Related]
7. Simple visualization of submicroscopic protein clusters with a phase-separation-based fluorescent reporter.
Mumford TR; Rae D; Brackhahn E; Idris A; Gonzalez-Martinez D; Pal AA; Chung MC; Guan J; Rhoades E; Bugaj LJ
Cell Syst; 2024 May; ():. PubMed ID: 38797172
[No Abstract] [Full Text] [Related]
8. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis.
Maya I; Yacobson S; Kahana S; Yeshaya J; Tenne T; Agmon-Fishman I; Cohen-Vig L; Shohat M; Basel-Vanagaite L; Sharony R
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):332-335. PubMed ID: 28133835
[TBL] [Abstract][Full Text] [Related]
9. Application of chromosomal microarray in fetuses with increased nuchal translucency.
Zhao XR; Gao L; Wu Y; Wang YL
J Matern Fetal Neonatal Med; 2020 May; 33(10):1749-1754. PubMed ID: 30688128
[No Abstract] [Full Text] [Related]
10. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of Noonan syndrome in fetuses with increased nuchal translucency and a normal karyotype.
Matyášová M; Dobšáková Z; Hiemerová M; Kadlecová J; Nikulenkov Grochová D; Popelínská E; Svobodová E; Vlašín P
Ceska Gynekol; 2019; 84(3):195-200. PubMed ID: 31324109
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal Microarray Analysis versus Karyotyping in Fetuses with Increased Nuchal Translucency.
Cicatiello R; Pignataro P; Izzo A; Mollo N; Pezone L; Maruotti GM; Sarno L; Sglavo G; Conti A; Genesio R; Nitsch L
Med Sci (Basel); 2019 Feb; 7(3):. PubMed ID: 30818867
[TBL] [Abstract][Full Text] [Related]
13. Whole exome sequencing in fetuses with isolated increased nuchal translucency: a systematic review and meta-analysis.
Di Girolamo R; Rizzo G; Khalil A; Alameddine S; Lisi G; Liberati M; Novelli A; D'Antonio F
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2193285. PubMed ID: 37019452
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic yield of next-generation sequencing in fetuses with isolated increased nuchal translucency: systematic review and meta-analysis.
Pauta M; Martinez-Portilla RJ; Borrell A
Ultrasound Obstet Gynecol; 2022 Jan; 59(1):26-32. PubMed ID: 34309942
[TBL] [Abstract][Full Text] [Related]
15. Genetic Examination for Fetuses with Increased Fetal Nuchal Translucency by Genomic Technology.
Xue S; Yan H; Chen J; Li N; Wang J; Liu Y; Zhang H; Li S; Zhang W; Chen D; Chen M
Cytogenet Genome Res; 2020; 160(2):57-62. PubMed ID: 32036363
[TBL] [Abstract][Full Text] [Related]
16. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
[TBL] [Abstract][Full Text] [Related]
17. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
[TBL] [Abstract][Full Text] [Related]
18. Fetal exome sequencing: yield and limitations in a tertiary referral center.
Daum H; Meiner V; Elpeleg O; Harel T;
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):80-86. PubMed ID: 29947050
[TBL] [Abstract][Full Text] [Related]
19. Increased nuchal translucency in fetuses with a normal karyotype-diagnosis and management: An observational study.
Socolov D; Socolov R; Gorduza VE; Butureanu T; Stanculescu R; Carauleanu A; Pavaleanu I
Medicine (Baltimore); 2017 Jul; 96(29):e7521. PubMed ID: 28723764
[TBL] [Abstract][Full Text] [Related]
20. Testing for Noonan syndrome after increased nuchal translucency.
Ali MM; Chasen ST; Norton ME
Prenat Diagn; 2017 Aug; 37(8):750-753. PubMed ID: 28569377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
